Type of Study:
Parallel assignment in participants with type 2 diabetes and cardiovascular risk
about 54 months
over 40 years, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.